• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体混浊的处理:综述。

Management of vitreous floaters: a review.

机构信息

David Geffen School of Medicine at UCLA, Los Angeles, CA.

Bascom Palmer Eye Institute, University of Miami Health System, Miami, FL.

出版信息

Curr Opin Ophthalmol. 2024 Sep 1;35(5):365-368. doi: 10.1097/ICU.0000000000001075. Epub 2024 Jul 11.

DOI:10.1097/ICU.0000000000001075
PMID:39046174
Abstract

PURPOSE OF REVIEW

Vitreous floaters, characterized by the perception of spots or shadows in the visual field, commonly result from posterior vitreous detachment and can cause chronic symptoms in affected patients. The diagnosis of posterior vitreous detachment is typically determined clinically and can sometimes be confirmed with optical coherence topography (OCT) [1 ▪▪ ] . The objective of this review is to review management options for symptomatic vitreous floaters.

RECENT FINDINGS

Symptoms of vitreous floaters may be mild or may significantly affect patient quality of life. Observation is the most common management strategy. Procedural management options include pars plana vitrectomy (PPV) and neodymium-doped yttrium aluminium garnet (Nd:YAG) vitreolysis. PPV is considered the most definitive management option for vitreous floaters. PPV, however, carries inherent risks, notably infection, cataract formation, and retinal detachment [2] . Nd:YAG laser vitreolysis is a less invasive alternative with studies demonstrating varied success [1 ▪▪ ,3,4] .

SUMMARY

This review provides insights into the current state of knowledge regarding the management of vitreous floaters and can guide clinical decision-making.

摘要

目的综述

玻璃体浮游物的特征是视野中有斑点或阴影的感觉,通常是由于后玻璃体脱离引起的,并可能导致受影响患者的慢性症状。后玻璃体脱离的诊断通常通过临床确定,有时可以通过光学相干断层扫描(OCT)[1▪▪]来确认。本综述的目的是回顾治疗有症状的玻璃体浮游物的选择。

最近的发现

玻璃体浮游物的症状可能较轻,也可能显著影响患者的生活质量。观察是最常见的治疗策略。治疗管理选择包括经睫状体平坦部玻璃体切除术(PPV)和钕掺杂钇铝石榴石(Nd:YAG)玻璃体切除术。PPV 被认为是玻璃体浮游物的最确定的治疗选择。然而,PPV 存在固有的风险,特别是感染、白内障形成和视网膜脱离[2]。Nd:YAG 激光玻璃体切除术是一种侵入性较小的替代方法,研究表明其成功率不同[1▪▪,3,4]。

总结

本综述提供了对玻璃体浮游物管理的当前知识状况的深入了解,并可以指导临床决策。

相似文献

1
Management of vitreous floaters: a review.玻璃体混浊的处理:综述。
Curr Opin Ophthalmol. 2024 Sep 1;35(5):365-368. doi: 10.1097/ICU.0000000000001075. Epub 2024 Jul 11.
2
Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.钕钇铝石榴石激光玻璃体溶解术与玻璃体切割术治疗玻璃体混浊的对比研究
Cochrane Database Syst Rev. 2017 Jun 1;6(6):CD011676. doi: 10.1002/14651858.CD011676.pub2.
3
Ocriplasmin for symptomatic vitreomacular adhesion.用于有症状性玻璃体黄斑粘连的奥克纤溶酶
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
4
Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.钕钇铝石榴石玻璃体溶解术和平坦部玻璃体切除术:玻璃体混浊的手术治疗
Eye (Lond). 2002 Jan;16(1):21-6. doi: 10.1038/sj.eye.6700026.
5
Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.新型光学相干断层扫描(OCT)应用与优化的钇铝石榴石(YAG)激光实现对中后段玻璃体混浊的可视化及治疗
Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 1;49(10):806-811. doi: 10.3928/23258160-20181002-10.
6
LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS.有症状玻璃体混浊患者的激光玻璃体溶解术
Cesk Slov Oftalmol. 2022 Fall;78(6):288-295. doi: 10.31348/2022/28.
7
Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.钕:钇-铝-石榴石激光玻璃体溶解术后玻璃体结构和视觉功能评估。
Ophthalmology. 2019 Nov;126(11):1517-1526. doi: 10.1016/j.ophtha.2019.06.021. Epub 2019 Jun 22.
8
Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report.Nd:YAG 激光治疗玻璃体混浊和后发性白内障后急性视网膜脱离:一例报告。
BMC Ophthalmol. 2020 Apr 19;20(1):157. doi: 10.1186/s12886-020-01428-7.
9
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
10
Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.早期 YAG 激光玻璃体切除术治疗症状性玻璃体浮游物的疗效和安全性:一项随机临床试验研究方案。
Trials. 2024 Jan 13;25(1):48. doi: 10.1186/s13063-024-07924-1.